Jack Nathan Medical Corp.

TSXV:JNH Stock Report

Market Cap: CA$4.4m

Jack Nathan Medical Past Earnings Performance

Past criteria checks 0/6

Jack Nathan Medical's earnings have been declining at an average annual rate of -19.6%, while the Healthcare industry saw earnings growing at 0.3% annually. Revenues have been growing at an average rate of 41.4% per year.

Key information

-19.6%

Earnings growth rate

-46.0%

EPS growth rate

Healthcare Industry Growth-6.7%
Revenue growth rate41.4%
Return on equityn/a
Net Margin-34.7%
Last Earnings Update31 Jan 2024

Recent past performance updates

Recent updates

Jack Nathan Medical Corp.'s (CVE:JNH) Shares Leap 30% Yet They're Still Not Telling The Full Story

Feb 07
Jack Nathan Medical Corp.'s (CVE:JNH) Shares Leap 30% Yet They're Still Not Telling The Full Story

Fewer Investors Than Expected Jumping On Jack Nathan Medical Corp. (CVE:JNH)

Oct 27
Fewer Investors Than Expected Jumping On Jack Nathan Medical Corp. (CVE:JNH)

Jack Nathan Medical Corp. (CVE:JNH) Insiders Increased Their Holdings

Dec 31
Jack Nathan Medical Corp. (CVE:JNH) Insiders Increased Their Holdings

Revenue & Expenses Breakdown
Beta

How Jack Nathan Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:JNH Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Jan 2419-7180
31 Oct 2317-8170
31 Jul 2317-7160
30 Apr 2316-6160
31 Jan 2315-7160
31 Oct 2216-6160
31 Jul 2214-7150
30 Apr 2212-8140
31 Jan 2210-8121
31 Oct 216-791
31 Jul 215-1470
30 Apr 214-1150
31 Jan 214-1040
31 Oct 204-930
31 Jul 204020
30 Apr 204-220
31 Jan 204-130
31 Jan 193210

Quality Earnings: JNH is currently unprofitable.

Growing Profit Margin: JNH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: JNH is unprofitable, and losses have increased over the past 5 years at a rate of 19.6% per year.

Accelerating Growth: Unable to compare JNH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: JNH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6.7%).


Return on Equity

High ROE: JNH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.